Abstract
DNA methylation of the FKBP5 gene is assumed to alter FKBP5 expression and hence the synthesis of the FK506 binding protein 51, a central element of a genomic negative feedback loop for glucocorticoid receptor signaling. The present study aimed to replicate and extend previously reported influences of FKBP5 genotypes, childhood maltreatment and depression on methylation levels of five CpG sites in intron 7 of the FKBP5 gene in a large population-based sample. Besides the single nucleotide polymorphism (SNP) rs1360780, associations of the FKBP5 methylation with 22 other, unlinked FKBP5 SNPs as well as associations between FKBP5 methylation levels and transcription levels were investigated. Using whole-blood methylation of 3965 subjects of the Study of Health in Pomerania (SHIP) reduced methylation levels in TT allele carriers of rs1360780 (OR = 0.975, p = .005) and currently depressed subjects (OR = 0.995, p = 0.005) were found. Further, an impact of two yet undescribed SNPs (rs6910300, rs7771727) on methylation levels was observed. However, main and interactive effects for childhood maltreatment and lifetime major depressive disorder observed in previous studies could not be replicated. Finally, FKBP5 methylation levels were not related to FKBP5 transcription levels in whole blood. Thus, the present study verified the associations of FKBP5 genotypes and state depression on the FKBP5 methylation levels of five CpG sites in intron 7. However, FKBP5 methylation of these five CpG sites could not be validated as a valuable clinical biomarker for biological long-term effects of childhood maltreatment or lifetime depression.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
König J, Block A, Becker M, Fenske K, Hertel J, Van der Auwera S, et al. Assessment of subjective emotional valence and long-lasting impact of life events: development and psychometrics of the Stralsund Life Event List (SEL). BMC Psychiatry. 2018;18:105 https://doi.org/10.1186/s12888-018-1649-3
Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology . 2009;34:S186–95. https://doi.org/10.1016/j.psyneuen.2009.05.021
Vermeer H, Hendriks-Stegeman BI, Van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab. 2003;88:277–84. https://doi.org/10.1210/jc.2002-020354
Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 2005;280:4609–16. https://doi.org/10.1074/jbc.M407498200
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33–41. https://doi.org/10.1038/nn.3275
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36:1319–25. https://doi.org/10.1038/ng1479
Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA. 2008;299:1291–305. https://doi.org/10.1001/jama.299.11.1291
Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141:4107–13. https://doi.org/10.1210/endo.141.11.7785
Höhne N, Poidinger M, Merz F, Pfister H, Bruckl T, Zimmermann P, et al. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int J Neuropsychopharmacol. 2014. https://doi.org/10.1093/ijnp/pyu087
Yehuda R, Daskalakis NP, Bierer LM, Bader HN, Klengel T, Holsboer F, Binder EB. Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol Psychiatry. 2016;80:372–80. https://doi.org/10.1016/j.biopsych.2015.08.005
Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology. 2011;36:1982–91. https://doi.org/10.1038/npp.2011.81
Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M, et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry. 2011;168:1107–16. https://doi.org/10.1176/appi.ajp.2011.10111577
Handwerger K. Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry. 2009;17:184–205. https://doi.org/10.1080/10673220902996775
Grabe HJ, Wittfeld K, Van der Auwera S, Janowitz D, Hegenscheid K, Habes M, et al. Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample. Hum Brain Mapp. 2016;37:1602–13. https://doi.org/10.1002/hbm.23123
Resmini E, Santos A, Aulinas A, Webb SM, Vives-Gilabert Y, Cox O, et al. Reduced DNA methylation of FKBP5 in Cushing’s syndrome. Endocrine. 2016. https://doi.org/10.1007/s12020-016-1083-6
Han K-M, Won E, Sim Y, Kang J, Han C, Kim Y-K, et al. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder. Sci Rep. 2017;7:42621 https://doi.org/10.1038/srep42621
Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci. 2009;66:2249–61. https://doi.org/10.1007/s00018-009-0015-5
Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005;74:481–14. https://doi.org/10.1146/annurev.biochem.74.010904.153721
Li E, Zhang Y. DNA methylation in mammals. Cold Spring Harb Perspect Biol. 2014;6:a019133 https://doi.org/10.1101/cshperspect.a019133
Razin A, Riggs AD. DNA methylation and gene function. Science. 1980;210:604–10.
Piyasena C, Cartier J, Provençal N, Wiechmann T, Khulan B, Sunderasan R, et al. Dynamic changes in DNA methylation occur during the first year of life in preterm infants. Front Endocrinol (Lausanne). 2016;7:158 https://doi.org/10.3389/fendo.2016.00158
Winkler BK, Lehnert H, Oster H, Kirchner H, Harbeck B. FKBP5 methylation as a possible marker for cortisol state and transient cortisol exposure in healthy human subjects. Epigenomics. 2017;9:1279–86. https://doi.org/10.2217/epi-2017-0057
Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294–307. https://doi.org/10.1093/ije/dyp394
Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA. 2005;102:15785–90. https://doi.org/10.1073/pnas.0507816102
Schurmann C, Heim K, Schillert A, Blankenberg S, Carstensen M, Dorr M, et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PLoS ONE. 2012;7:e50938 https://doi.org/10.1371/journal.pone.0050938
Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abus Negl. 2003;27:169–90. https://doi.org/10.1016/S0145-2134(02)00541-0
Wittchen H-U. DIA-X-Interviews: Manual für Screening Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittsuntersuchung (DIA-X-12 Monate); Ergänzungsheft (DIA-X-12 Monate). Frankfurt: Swets & Zeitlinger; 1997.
Wittchen H-U, Pfister H. Diagnostisches Expertensystem für psychische Störungen. Frankfurt: Swets & Zeitlinger; 1997.
Beck AT, Steer RA, Brown G. Manual for the Beck Depression Inventory-II. San Antonio: The Psychological Corporation; 1996.
Wahl I, Lowe B, Bjorner JB, Fischer F, Langs G, Voderholzer U, et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol. 2014;67:73–86. https://doi.org/10.1016/j.jclinepi.2013.04.019
Hertel J, König J, Homuth G, Van der Auwera S, Wittfeld K, Pietzner M, et al. Evidence for stress-like alterations in the HPA-Axis in women taking oral contraceptives. Sci Rep. 2017;7:14111 https://doi.org/10.1038/s41598-017-13927-7
Papke LE, Wooldridge JM. Econometric methods for fractional response variables with an application to 401(k) plan participation rates. J Appl Econ. 1996;11:619–32. https://doi.org/10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
Roy B, Shelton RC, Dwivedi Y. DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation. J Psychiatr Res. 2017;89:115–24. https://doi.org/10.1016/j.jpsychires.2017.02.005
Wahl S, Fenske N, Zeilinger S, Suhre K, Gieger C, Waldenberger M, et al. On the potential of models for location and scale for genome-wide DNA methylation data. BMC Bioinforma. 2014;15:232 https://doi.org/10.1186/1471-2105-15-232
Danese A, Tan MT. Childhood maltreatment and obesity: systematic review and meta-analysis. Mol Psychiatry. 2014;19:544–54. https://doi.org/10.1038/mp.2013.54
Dannlowski U, Stuhrmann A, Beutelmann V, Zwanzger P, Lenzen T, Grotegerd D, et al. Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry. 2012;71:286–93. https://doi.org/10.1016/j.biopsych.2011.10.021
Downs WR, Harrison L. Childhood maltreatment and the risk of substance problems in later life. Health Soc Care Community. 1998;6:35–46.
Li M, D’Arcy C, Meng X. Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions. Psychol Med. 2016;46:717–30. https://doi.org/10.1017/S0033291715002743
Molendijk ML, Hoek HW, Brewerton TD, Elzinga BM. Childhood maltreatment and eating disorder pathology: a systematic review and dose-response meta-analysis. Psychol Med. 2017:1–15. https://doi.org/10.1017/S0033291716003561.
Lee RS, Tamashiro KLK, Yang X, Purcell RH, Harvey A, Willour VL, et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology. 2010;151:4332–43. https://doi.org/10.1210/en.2010-0225
Bustamante AC, Aiello AE, Guffanti G, Galea S, Wildman DE, Uddin M. FKBP5 DNA methylation does not mediate the association between childhood maltreatment and depression symptom severity in the Detroit Neighborhood Health Study. J Psychiatr Res. 2018;96:39–48. https://doi.org/10.1016/j.jpsychires.2017.09.016
Matsuda A, Asada Y, Takakuwa K, Sugita J, Murakami A, Ebihara N. DNA Methylation Analysis of Human Trabecular Meshwork Cells During Dexamethasone Stimulation. Invest Ophthalmol Vis Sci. 2015;56:3801–9. https://doi.org/10.1167/iovs.14-16008
Needham BL, Smith JA, Zhao W, Wang X, Mukherjee B, Kardia SLR, et al. Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: The multi-ethnic study of atherosclerosis. Epigenetics. 2015;10:958–69. https://doi.org/10.1080/15592294.2015.1085139
Paquette AG, Lester BM, Koestler DC, Lesseur C, Armstrong DA, Marsit CJ. Placental FKBP5 genetic and epigenetic variation is associated with infant neurobehavioral outcomes in the RICHS cohort. PLoS ONE. 2014;9:e104913 https://doi.org/10.1371/journal.pone.0104913
Ewald ER, Wand GS, Seifuddin F, Yang X, Tamashiro KL, Potash JB, et al. Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure. Psychoneuroendocrinology . 2014;44:112–22. https://doi.org/10.1016/j.psyneuen.2014.03.003
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Klinger-König, J., Hertel, J., Van der Auwera, S. et al. Methylation of the FKBP5 gene in association with FKBP5 genotypes, childhood maltreatment and depression. Neuropsychopharmacol. 44, 930–938 (2019). https://doi.org/10.1038/s41386-019-0319-6
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41386-019-0319-6
This article is cited by
-
Independent, Multiplicative, and Cumulative Effects of Recent Stressful Life Events and Adverse Childhood Events on Depressive Symptoms among College Students: Moderation by the HPA-axis Multilocus Genetic Variation
Journal of Youth and Adolescence (2025)
-
The association of FKBP5 gene polymorphism with genetic susceptibility to depression and response to antidepressant treatment- a systematic review
BMC Psychiatry (2024)
-
Epigenetic differences in stress response gene FKBP5 among children with abusive vs accidental injuries
Pediatric Research (2023)
-
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
Signal Transduction and Targeted Therapy (2023)
-
The association of FKBP5 gene methylation, adolescents’ sex, and depressive symptoms among Chinese adolescents: a nested case-control study
BMC Psychiatry (2022)
